Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B.
about
Spontaneous resolution of de novo hepatitis B after living donor liver transplantation with hepatitis B core antibody positive graft: a case report.Quantitative Levels of Hepatitis B Virus DNA and Surface Antigen and the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Receiving Long-Term Nucleos(t)ide Analogue TherapyReactivation of hepatitis B virus in patients receiving chemotherapy.Combination therapy with a nucleos(t)ide analogue and interferon for chronic hepatitis B: simultaneous or sequential.Guidelines for avoiding risks resulting from discontinuation of nucleoside/nucleotide analogs in patients with chronic hepatitis B.A proposal for management of rheumatic disease patients with hepatitis B virus infection receiving immunosuppressive therapy.Combination therapy of interferon and nucleotide/nucleoside analogues for chronic hepatitis B.Sustained Off-Treatment Response After Discontinuation of Long-Term Nucleos(t)ide Analogue Treatment in HBeAg-Seronegative Hepatitis B: A Case Series.Combinational use of hepatitis B viral antigens predicts responses to nucleos(t)ide analogue/peg-interferon sequential therapy.Clinical outcomes and predictors for relapse after cessation of oral antiviral treatment in chronic hepatitis B patients.Hepatitis B surface antigen reduction by switching from long-term nucleoside/nucleotide analogue administration to pegylated interferon.Hepatitis B virus core-related antigen as a surrogate marker for covalently closed circular DNA.Factors associated with the effect of interferon-α sequential therapy in order to discontinue nucleoside/nucleotide analog treatment in patients with chronic hepatitis B.JSH Guidelines for the Management of Hepatitis B Virus Infection.Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients.Hepatitis B core-related antigen: a strong indicator for cessation of nucleos(t)ide analog therapy in patients with chronic hepatitis B.Entecavir and interferon-α sequential therapy in Japanese patients with hepatitis B e antigen-positive chronic hepatitis B.Changes in the serum level of hepatitis B virus (HBV) surface antigen over the natural course of HBV infection.Association of on-treatment serum hepatitis B surface antigen level with sustained virological response to nucleos(t)ide analog in patients with hepatitis B e-antigen positive chronic hepatitis B.Anti-hepatitis B virus therapy: To stop, or not to stop: Has the question been solved?Impact of peginterferon alpha-2b and entecavir hydrate combination therapy on persistent viral suppression in patients with chronic hepatitis B.48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse.
P2860
Q37372998-8F8AA00A-AB76-47D6-B47D-D2213A053738Q37716237-28FB29A3-83DF-4FC2-AD98-EE57BC92474BQ38062818-54ED1EF1-8247-470A-9AC9-713FD98767E6Q38075796-3D5539C1-B314-4226-B525-BE3C0491C13DQ38100847-DCABA402-EB09-42E3-A249-856DED023987Q38164830-F95B9707-8BDE-4826-B9F2-48FE2C866417Q38268743-A5DBAB6F-BA3F-4EF1-B5F8-C6E512EDD9C8Q40088040-B0BF6668-4360-4B97-BD43-B2991A646159Q40151821-6600D90E-3FF1-4871-8E0B-33BFE20688FAQ40189344-8C31CC37-D57A-4B75-911D-6BBCDCE3CDD4Q40335324-10C88744-6FAA-44D6-91A6-3EA36926CC84Q40404314-5C4FA81A-E197-4211-B675-984547669AE4Q42174830-9742885C-2A92-4324-81DA-F8B4D0A3ACF1Q42244740-58D12B94-742D-4EF8-9998-27BEA3A654F5Q43950558-E60929A7-C491-4398-97ED-88CFFD7AF855Q43975290-91BC0EB7-4CD7-4A9D-87F6-FFEB41FD02A1Q44082487-B043F76A-94C2-4252-BD23-8FDB0D0ABA51Q44646819-6345825C-D942-4196-B344-6B2DC860DD48Q45067577-5458DCAD-93D8-49D7-ADC0-E7FFE1AFFBC1Q45355602-E419ED53-AA79-4CE6-ADC0-058D345526CFQ46200437-99C9B676-AAAC-4292-82B7-37BAFC9DA32EQ55396049-DDDFA76E-CF72-456D-A583-B2EE857001FA
P2860
Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Combination of hepatitis B vir ...... ter discontinuation of nucleos
@nl
Combination of hepatitis B vir ...... ents with chronic hepatitis B.
@en
type
label
Combination of hepatitis B vir ...... ter discontinuation of nucleos
@nl
Combination of hepatitis B vir ...... ents with chronic hepatitis B.
@en
prefLabel
Combination of hepatitis B vir ...... ter discontinuation of nucleos
@nl
Combination of hepatitis B vir ...... ents with chronic hepatitis B.
@en
P2093
P2860
P1433
P1476
Combination of hepatitis B vir ...... ents with chronic hepatitis B.
@en
P2093
Akihiro Matsumoto
Eiji Tanaka
Fumio Imazeki
Hiromitsu Kumada
Hiroshi Yatsuhashi
Kazuaki Chayama
Kei Fujiwara
Mariko Kobayashi
Masaki Saito
Masataka Tsuge
P2860
P304
P356
10.1111/J.1872-034X.2011.00910.X
P577
2011-11-22T00:00:00Z